Related Experiment Video
Updated: Jan 25, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling
Tomoki Yoshioka1, Tomoki Kosugi2, Tomohiro Masuda2
1Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Abstract:
Podocytes, which are susceptible to injury by various stimuli and stress, are critical regulators of proteinuric kidney diseases, regardless of the primary disease and pathogenesis. We further confirmed a significant correlation between urinary CD147/basigin (Bsg) levels and proteinuria in patients with focal segmental glomerulosclerosis. However, the molecular mechanism of podocyte injury involving Bsg is not fully understood. Here, the involvement of Bsg in the pathogenesis of podocyte injury was elucidated. Healthy podocytes rarely express Bsg protein. In two independent mouse models, including adriamycin-induced nephropathy and Nω-nitro-l-arginine methyl ester (l-name)-induced endothelial dysfunction, Bsg induction in injured podocytes caused podocyte effacement, which led to development of proteinuria. Bsg silencing in cultured podocytes exposed to transforming growth factor-β suppressed focal adhesion rearrangement and cellular motility via the activation of β1 integrin-focal adhesion kinase-matrix metallopeptidase signaling. In addition, induction of vascular endothelial growth factor and endothelin-1, which are implicated in podocyte-to-endothelial cross-communication, was lower in the supernatants of cultured Bsg-silenced podocytes stimulated with transforming growth factor-β. In this setting, Bsg may be involved in a physiological positive feedback loop that accelerates podocyte cell motility and depolarization. The current study thus suggests that Bsg silencing via suppression of β1 integrin-focal adhesion kinase-matrix metallopeptidase signaling may be an attractive therapeutic strategy for the maintenance of podocytes in patients with proteinuric kidney diseases.
Insights
Basigin (Bsg) protein is upregulated in injured podocytes, contributing to proteinuria in kidney disease. Silencing Bsg may protect podocytes by inhibiting cell motility and signaling pathways, offering a potential therapeutic strategy.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Podocytes are crucial for kidney function and susceptible to injury, leading to proteinuric kidney diseases.
- Urinary CD147/basigin (Bsg) levels correlate with proteinuria in focal segmental glomerulosclerosis patients.
- The precise role of Bsg in podocyte injury remains unclear.
Purpose of the Study:
- To elucidate the involvement of Bsg in the pathogenesis of podocyte injury.
- To investigate the molecular mechanisms by which Bsg influences podocyte function and injury.
- To explore Bsg silencing as a potential therapeutic strategy for proteinuric kidney diseases.
Main Methods:
- Utilized two independent mouse models: adriamycin-induced nephropathy and L-NAME-induced endothelial dysfunction.
- Examined Bsg expression in podocytes under normal and injured conditions.
- Performed Bsg silencing in cultured podocytes stimulated with transforming growth factor-β (TGF-β).
- Analyzed focal adhesion dynamics, cellular motility, and signaling pathways (β1 integrin-FAK-MMP).
- Measured levels of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in cell culture supernatants.
Main Results:
- Bsg protein is minimally expressed in healthy podocytes but induced upon injury.
- Bsg induction in podocytes of mouse models led to podocyte effacement and proteinuria.
- Bsg silencing in TGF-β-stimulated podocytes suppressed focal adhesion rearrangement and motility via the β1 integrin-FAK-MMP pathway.
- Bsg silencing reduced the induction of VEGF and ET-1 in TGF-β-stimulated podocytes.
- Bsg appears to participate in a positive feedback loop promoting podocyte motility and depolarization.
Conclusions:
- Bsg plays a significant role in podocyte injury and the development of proteinuria.
- Bsg silencing, by inhibiting the β1 integrin-FAK-MMP signaling pathway, offers a promising therapeutic approach.
- Targeting Bsg may be a viable strategy to preserve podocyte integrity in proteinuric kidney diseases.
More Related Videos
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
What is Cell Signaling?
Paracrine Signaling

